top of page

 

Completed supervision of doctoral and post-doctoral students;



​Robert Blizzard 1990;

Bessel function and Edgeworth approximations for permutation distributions.

Current position: Professor of Biostatistics, University College London. 



Fabienne Pessione 1992 ;
Inversion of regression  effect in survival studies: applications in bone marrow transplantation

Current position: Epidemiologist, Hôpital Beaujon, Clichy, France.

Sylvie Chevret 1994 ;
Impact of model choice in a Phase I clinical trial.

Current position: Professor of Biostatistics and Medical Informatics, Hôpital Saint Louis, Paris, France.

Larry Shen 1994 ;
Asymptotic theory of stochastic approximation methods.
Current position; Chief of Biostatistics. Amylin Pharmaceuticals, San Diego, California.

Philippe Flandre 1995;
Surrogate endpoints in survival studies; application to clinical trials in AIDS.
Current position: Senior Research Scientist, AIDS Clinical Trials Group, Villejuif, France.

​Ethan Reiner 1996;

Stopping rules for stochastically curtailed clinical trials.

Current position: Manager, Axa Investments, Paris, France



Ronghui Xu 1997;
Inference for the proportional hazards model

Current position: Full Professor, Dept. of Mathematics, University of California at San Diego.

Reena Deutsch 1997;

Incubation period of the HIV virus

Current position: Professor, Cancer Center, University of California at San Diego.

Cécile Parent 1998;
Change point models in survival analysis; application to breast cancer studies.
Current position: Unknown.
 

Katherine Gower 1999;
Models for carcinogenesis.
Current position: Statistician, Fred Hutchinson Cancer Research Center, Seattle.

Laurent Vabre 2000 ;
Incorporating PK/PD information into Phase I dose finding designs.
Current position: Epidemiologist/Practitioner RATP, Paris, France.

 

Xavier Paoletti 2002;

Optimality in Phase I and Phase II dose finding studies.
Current position: Associate Director of Biostatistics. Institut Curie, Paris, France.

Sarah Zohar 2005;
Efficiency of dose finding studies in cancer based on combining toxicity and treatment efficacy information

Current position: Inserm Researcher, Centre d'Investigation Clinique  (equivalent to CRC), Hôpital Saint Louis, Paris.

Nolan Wages 2010;

Dose finding designs for drug combinations.
Current position: Assistant Professor, Division of Biostatistics, University of Virginia.
 
Jianfen Shu 2012;
Heterogeneity models in dose finding studies.
Current position: Senior Statistician, PharmaNet/i3 International. California. U.S.A.

 

Cécile Chauvel 2014

Influence of model assumptions on prediction in survival models. 

Current position: Senior Statistician, AXA, Grenoble.

 

Matthieu Clertant 2015

Inference for hierarchical statistical models. 
Current position: Assistant Professor, Lancaster University, U.K. 

Roxane Duroux 2016
Robustness of dose-finding algorithms in non-standard settings.

Current position: Professor Education Nationale, France.

David Guédé (Ph.d thesis)
Bayesian dose finding trials in healthy volunteers.

 

Christophe Peczynski (Ph.d thesis)

Clinical trials using smart data

Current position: Statistician, AdScientiam, Paris.

bottom of page